Navigation Links
PHARMORX Security And MSO Announce Joint Venture
Date:3/16/2009

Serialization and Authentication Technology & Services Provider Teams Up with Specialty Print Packaging Materials Company to Offer End-To-End Customized Security Solutions for Multiple Industries

Southborough, MA (PRWEB) March 16, 2009 -- PHARMORX Security™, a leading serialization, authentication, and track and trace technology and services provider, recently entered into a collaboration agreement with MSO Group™, Ltd, a manufacturer of specialty, high-quality labels and cartons, headquartered in Belfast, Ireland. The businesses, which both maintain a focus on product security, consumer protection and brand integrity, have joined forces to provide comprehensive solutions to address multiple industry concerns regarding counterfeiting, diversion and traceability.

The companies have developed integrated solutions for the pharmaceutical, tobacco and beverage industries, among others, which effectively address existing security issues within the supply chain. These new solutions, which combine MSO advanced packaging products with PHARMORX technologies and services, combat counterfeiting, diversion, and return-management issues by offering manufacturers the ability to track their products from distributor to wholesaler, through to the retailer, and in some cases to the consumer.

"By combining our efforts and our technologies with those of MSO, we are able to offer clients multiple layers of security protection, as well as extend our reach creating a two-way security solutions distribution channel," stated PHARMORX president and CEO, Steve Wood. Working with a high-end packaging materials company such as MSO, we're able to provide a whole-product solution, including security assessments, product and brand strategy implementation plans, security label design, as well as printing equipment and packaging material," he added.

PHARMORX and MSO partner to provide serialization for track and trace and diversion control, offering unit-level product identification via variable data printing of 2D barcodes and human-readable codes. The companies also provide authentication solutions for anti-counterfeiting through development of labels and cartons marked with proprietary multi-wavelength taggants and invisible inks for authentication in the field by trading partners, consumers, and law enforcement.

"Working with PHARMORX we're able to provide our customers the most user friendly item code and traceability history," stated MSO Chief Executive Officer, Dominic Walsh. "We reviewed many potential solutions
and selected PHARMORX and the AuthentiTrack solution as it provides the most user friendly and reliable item code traceability history. We are delighted to have teamed up with PHARMORX for this joint venture. I believe that the strengths of both companies are an excellent complement to each other, and know that together we have the solution for product security and brand integrity, to continue the ongoing battle against counterfeiting and diversion control," he added.

PHARMORX Security and MSO will be demonstrating their serialization and authentication solutions at this year's INTERPHEX show in Booth 3261.

About PHARMORX Security

Headquartered in Southborough, Massachusetts, PHARMORX Security offers anti-counterfeiting, diversion control and track & trace technologies and services from the point of manufacture through to the consumer. Uniquely, PHARMORX provides solutions from unit level authentication and verification to serialization of all levels of packaging. Our security offerings are applied in layers, from simple labels and cartons with proprietary taggants to sophisticated web-based serialization solutions that provide the brand manufacturer with knowledge of the product's entire life history and disposition. By combining these various layers of security, a product travels from manufacturing, through packaging, into distribution, through the retailer's point of sale, and into the hands of the consumer with maximum traceability, safety and integrity. www.pharmorx.com.

About MSO Group Ltd

With facilities in Belfast, Ireland, and Leicester, England, MSO Group Ltd, MSO is a manufacturer of specialty, high-quality labels and cartons. With over one hundred years of experience in developing customized packaging materials, and a focus on brand protection, the company has incorporated many unique anti-counterfeiting measures into its packaging development technologies. MSO provides packaging materials to some of the largest brands in the marketplace, such as Diageo, Hewlett Packard, Oki, and GlaxoSmithKline. www.msocleland.com
Serialization and Authentication Technology & Services Provider Teams Up with Specialty Print Packaging Materials Company to Offer End-To-End Customized Security Solutions for Multiple Industries

Contact: Maureen Perroni _ 603.929.6664

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2235944.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Presidential Candidates Address Health, Financial Security at AARPs Life@50+
2. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
3. Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry
4. Report highlights inadequate pandemic planning as a threat to EU security
5. PinnacleHealth System Selects Phoenix Health Systems to Provide HIPAA Security Assessment Services
6. Vendormate VISION 4.0(TM) Streamlines Healthcare Security and Compliance Efforts
7. HITSP Defines Overarching Set of Healthcare Security and Privacy Standards
8. New Records & Information Management: Are You Spending Right on Records Management, Data Security and Compliance?
9. Divided We Fail Faith Week to Raise Health and Financial Security Issues in Communities of Faith
10. TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems
11. New T-ray Source Could Improve Airport Security, Cancer Detection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PHARMORX Security And MSO Announce Joint Venture 
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest ... readers to sign up as an organ donor for the 123,000 people in the ... organ donor can save up to 8 saves through organ donation and enhance many ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... program through the Pennsylvania Cable Network (PCN) during the summer of 2016. The ... Implementation Grant provided by the United States Department of Health and Human Services ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa ... Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies ... few hospitals and facilities have earned this distinction. This is the second time ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
Breaking Medicine Technology: